https://www.selleckchem.com/pr....oducts/GSK461364.htm
To assess the diagnostic performance of ultrasound (US) attenuation imaging (ATI) for diagnosis and grading of hepatic steatosis with comparison to magnetic resonance imaging-proton density fat fraction (MRI-PDFF) using mDIXON-Quant sequence. Total 100 patients who underwent abdominal US ATI and MRI-PDFF within one month were included. Subjects were divided into three groups according to MRI-PDFF; Group 1 (no fatty liver), Q5.1%; Group 2 (mild fatty liver), 5.1%≤Q14.1%; and Group 3 (moderate fatty liver), Q≥14.1%. US attenuati
Like
Comment
Share
